SE8003243L - 5-(2-( (2,3-dihydro-1,4-bensodioxan-2-ylmetyl)-amino)-1-hydroxietyl)-2-hydroxibensoesyraderivat och sett att framstella dessa - Google Patents
5-(2-( (2,3-dihydro-1,4-bensodioxan-2-ylmetyl)-amino)-1-hydroxietyl)-2-hydroxibensoesyraderivat och sett att framstella dessaInfo
- Publication number
- SE8003243L SE8003243L SE8003243A SE8003243A SE8003243L SE 8003243 L SE8003243 L SE 8003243L SE 8003243 A SE8003243 A SE 8003243A SE 8003243 A SE8003243 A SE 8003243A SE 8003243 L SE8003243 L SE 8003243L
- Authority
- SE
- Sweden
- Prior art keywords
- benzodioxan
- ylmethyl
- dihydro
- hydroxyethyl
- amino
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 102000004305 alpha Adrenergic Receptors Human genes 0.000 abstract 1
- 108090000861 alpha Adrenergic Receptors Proteins 0.000 abstract 1
- 229940030600 antihypertensive agent Drugs 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 102000012740 beta Adrenergic Receptors Human genes 0.000 abstract 1
- 108010079452 beta Adrenergic Receptors Proteins 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 229960004889 salicylic acid Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/036,243 US4206125A (en) | 1979-05-04 | 1979-05-04 | 5-[2-[(2,3-Dihydro-1,4-benzodioxan-2-ylmethyl)amino]-1-hydroxyethyl]-2-hydroxybenzoic acid derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8003243L true SE8003243L (sv) | 1980-11-05 |
| SE434745B SE434745B (sv) | 1984-08-13 |
Family
ID=21887496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8003243A SE434745B (sv) | 1979-05-04 | 1980-04-29 | 5-(2-( (2,3-dihydro-1,4-bensodioxan-2-ylmetyl)-amino)-1-hydroxietyl)-2-hydroxibensoesyraderivat och sett att framstella dessa |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4206125A (sv) |
| JP (1) | JPS55147274A (sv) |
| AT (1) | AT369365B (sv) |
| AU (1) | AU531739B2 (sv) |
| BE (1) | BE883087A (sv) |
| CA (1) | CA1148963A (sv) |
| CH (1) | CH645372A5 (sv) |
| DE (1) | DE3014738A1 (sv) |
| DK (1) | DK154503C (sv) |
| ES (1) | ES490814A0 (sv) |
| FR (1) | FR2455598A1 (sv) |
| GB (1) | GB2051780B (sv) |
| IE (1) | IE49564B1 (sv) |
| IL (1) | IL59681A (sv) |
| IT (1) | IT1127441B (sv) |
| NL (1) | NL8002208A (sv) |
| NO (1) | NO153572C (sv) |
| NZ (1) | NZ193236A (sv) |
| PH (1) | PH15963A (sv) |
| SE (1) | SE434745B (sv) |
| ZA (1) | ZA801603B (sv) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU204285B (en) * | 1986-10-31 | 1991-12-30 | Pfizer | Process for producing renin-inhibiting polypeptides of small molecule mass and pharmaceutical compositions containing them |
| JP2931986B2 (ja) * | 1989-02-17 | 1999-08-09 | 武田薬品工業株式会社 | アラルキルアミン誘導体 |
| ES2291733T3 (es) * | 2002-10-22 | 2008-03-01 | Glaxo Group Limited | Compuestos de ariletanolamina medicinales. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1054104A (sv) * | 1962-07-20 | |||
| US3514465A (en) * | 1966-12-30 | 1970-05-26 | Degussa | Certain thiazolyl- and pyridinylaminoketones |
| US3883560A (en) * | 1973-07-05 | 1975-05-13 | Colgate Palmolive Co | Salicylamidophenethanolamines |
| CA1147342A (en) * | 1977-10-12 | 1983-05-31 | Kazuo Imai | Process of producing novel phenylethanolamine derivatives |
| JPS55124742A (en) * | 1979-03-20 | 1980-09-26 | Kyowa Hakko Kogyo Co Ltd | Novel aminoalcohol derivative |
-
1979
- 1979-05-04 US US06/036,243 patent/US4206125A/en not_active Expired - Lifetime
-
1980
- 1980-03-19 ZA ZA00801603A patent/ZA801603B/xx unknown
- 1980-03-20 IE IE572/80A patent/IE49564B1/en not_active IP Right Cessation
- 1980-03-21 IL IL59681A patent/IL59681A/xx unknown
- 1980-03-24 NZ NZ193236A patent/NZ193236A/xx unknown
- 1980-03-28 PH PH23837A patent/PH15963A/en unknown
- 1980-04-02 AU AU57077/80A patent/AU531739B2/en not_active Expired
- 1980-04-09 IT IT48373/80A patent/IT1127441B/it active
- 1980-04-16 NL NL8002208A patent/NL8002208A/nl not_active Application Discontinuation
- 1980-04-17 DE DE19803014738 patent/DE3014738A1/de active Granted
- 1980-04-17 CA CA000350104A patent/CA1148963A/en not_active Expired
- 1980-04-18 JP JP5054980A patent/JPS55147274A/ja active Granted
- 1980-04-22 CH CH309380A patent/CH645372A5/de not_active IP Right Cessation
- 1980-04-23 ES ES490814A patent/ES490814A0/es active Granted
- 1980-04-25 GB GB8013770A patent/GB2051780B/en not_active Expired
- 1980-04-29 SE SE8003243A patent/SE434745B/sv not_active IP Right Cessation
- 1980-04-30 FR FR8009849A patent/FR2455598A1/fr active Granted
- 1980-04-30 AT AT0232780A patent/AT369365B/de not_active IP Right Cessation
- 1980-05-01 DK DK193580A patent/DK154503C/da not_active IP Right Cessation
- 1980-05-02 NO NO801296A patent/NO153572C/no unknown
- 1980-05-02 BE BE0/200447A patent/BE883087A/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IT1127441B (it) | 1986-05-21 |
| DK154503C (da) | 1989-04-10 |
| IE49564B1 (en) | 1985-10-30 |
| ES8104997A1 (es) | 1981-05-16 |
| IL59681A0 (en) | 1980-06-30 |
| AU531739B2 (en) | 1983-09-01 |
| IT8048373A0 (it) | 1980-04-09 |
| AU5707780A (en) | 1980-11-06 |
| ZA801603B (en) | 1981-03-25 |
| NO153572B (no) | 1986-01-06 |
| BE883087A (fr) | 1980-09-01 |
| NL8002208A (nl) | 1980-11-06 |
| FR2455598B1 (sv) | 1983-05-27 |
| DK193580A (da) | 1980-11-05 |
| DE3014738C2 (sv) | 1989-08-03 |
| PH15963A (en) | 1983-05-04 |
| JPS642115B2 (sv) | 1989-01-13 |
| ATA232780A (de) | 1982-05-15 |
| JPS55147274A (en) | 1980-11-17 |
| AT369365B (de) | 1982-12-27 |
| GB2051780B (en) | 1982-12-22 |
| GB2051780A (en) | 1981-01-21 |
| ES490814A0 (es) | 1981-05-16 |
| NZ193236A (en) | 1982-09-14 |
| NO801296L (no) | 1980-11-05 |
| CH645372A5 (de) | 1984-09-28 |
| DE3014738A1 (de) | 1980-11-13 |
| FR2455598A1 (fr) | 1980-11-28 |
| US4206125A (en) | 1980-06-03 |
| DK154503B (da) | 1988-11-21 |
| SE434745B (sv) | 1984-08-13 |
| CA1148963A (en) | 1983-06-28 |
| IL59681A (en) | 1984-04-30 |
| NO153572C (no) | 1986-04-16 |
| IE800572L (en) | 1980-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT98710A (pt) | Processo de preparacao de compostos de indolilo substituidos e de composicoes farmaceuticas que os contem | |
| NO924310L (no) | Nevrobeskyttende indolon- og beslektede derivater | |
| ES516561A0 (es) | Procedimiento para la obtencion de acidos 1-carboxi-(alcanoil o aralcanoil)-indolin-2-carboxilicos. | |
| SE8302693L (sv) | Heterocykliska foreningar | |
| FI912142L (sv) | Förfarande för framställning av nya, terapeutiskt användbara 5-(2-((2-aryl-hydroxietyl)amino)propyl)-1,3-benzodioxolderivat | |
| PT89814A (pt) | Processo para a preparacao de novos derivados do estilbeno e de composicoes farmaceuticas que os contem | |
| BR9712507A (pt) | Derivados de aminotiazol, seu processo de preparo e as composições famacêuticas que os comtêm. | |
| SE7603085L (sv) | Diazepinderivat | |
| ES496038A0 (es) | Procedimiento para la obtencion de 2-hidroxialquil-3,4,5- trihidroxi-piperidinas | |
| FI812106L (fi) | Nya imidazolderivat foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska produkter | |
| PT97991A (pt) | Processo para a preparacao de derivados de 2-(aminoalquil)-5-(arilalquil)-1,3-dioxanos e de composicoes farmaceuticas que os contem | |
| SE8003243L (sv) | 5-(2-( (2,3-dihydro-1,4-bensodioxan-2-ylmetyl)-amino)-1-hydroxietyl)-2-hydroxibensoesyraderivat och sett att framstella dessa | |
| ES492143A0 (es) | Procedimiento para la obtencion de derivados de 3,4,5-trihi-droxipiperidina | |
| SE8003244L (sv) | 2-hydroxi-5-(1-hydroxi-2-piperazinyletyl)-bensoesyraderivat och sett att framstella dessa | |
| ES497693A0 (es) | Procedimiento para la obtencion de derivados de benzotiazol | |
| FI852743L (fi) | Acetyleniska fenoxipropanolderivat och farmaceutiska kompositioner foer behandling av hypertoni. | |
| DK149590C (da) | Analogifremgangsmaade til fremstilling af 2-aryl-3,4-diaza-bicyclo(4,1,0)hepten-(2)-on-(5)-forbindelser | |
| FI833119A0 (fi) | Substituerade bensensulfonylsyraestrar, foerfaranden foer deras framstaellning och anvaendning daersom laekemedel | |
| SE8503225D0 (sv) | Diacyloxi-1,8-acyl-10-antroner, sett for deras framstellning och deras anvendning som lekemedel for djur och menniska samt for kosmetika | |
| AR223969A1 (es) | Derivados de 2-(3'-(fenoxi)-fenoxi)oxazolina,procedimiento para su preparacion y agentes herbicidas que los contienen | |
| ES523379A0 (es) | Procedimiento para la obtencion de un derivado de organofosfato. | |
| SE7910612L (sv) | Metod att kontrollera hypertension och intestinala sjukdomar samt kompositioner | |
| ES497737A0 (es) | Procedimiento para la obtencion de la n-(2-((5-((dimetilami-no)metil)furfuril)tio)etil)-n'- metil -2- nitro-1,1- eteno- diamina | |
| ES523235A0 (es) | "procedimiento para la preparacion de n-(2-(((5-(dimetilamino)-metil-2-furanil) metil) tio) etil) -n'- metil-2-nitro 1,1-etenodiamina" | |
| ES543966A0 (es) | Procedimiento para la preparacion de la n-(2-(((5-(dimetila-mino)-metil-2-furanil)metil)tio)etil)-n'-metil-2-nitro-1,1- etendiamina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 8003243-6 Format of ref document f/p: F |
|
| NUG | Patent has lapsed |
Ref document number: 8003243-6 Format of ref document f/p: F |